UNSPSC 51162345: Belladonna/chlorpheniramine/phenylephrine/pyrilamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

UNSPSC 51162345 Belladonna/chlorpheniramine/phenylephrine/pyrilamine is a Commodity code, but recent state and local solicitations show little activity aligned with this specific pharmaceutical formulation. Instead, the tagged opportunities reflect broader pharmaceutical procurement — naloxone and drug deactivation systems at the county level, and generic multi-source pharmaceuticals and OTC products through a multistate cooperative purchasing vehicle — neither of which are belladonna-containing compounds. The mismatch suggests either tagging inconsistency in the source data or that this particular drug combination sees minimal procurement demand from state and local buyers at present.

The two opportunities on record come from Seminole County, Florida (an IFB for naloxone and safe drug deactivation systems, due July 26, 2023) and the Minnesota Multistate Cooperative Purchasing Alliance, administered by the Minnesota Department of Administration (an RFP for generic pharmaceuticals and OTC products, due March 26, 2026). The latter represents cooperative purchasing across multiple states and local facilities, while the former is a discrete county health procurement. No recent solicitations specifically target belladonna-based formulations, and no pattern of repeat buyers or geographic concentration under this code is evident from the available opportunities. Firms interested in pharmaceutical supply to state and local health systems should monitor broader generic pharmaceutical and OTC RFPs, but direct demand for this particular drug combination does not appear active in current state and local procurement pipelines.